Oral immunization with F4 fimbriae and CpG formulated with Carboxymethyl Starch enhances F4-specific mucosal immune response and modulates Th1 and Th2 cytokines in weaned pigs

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 15, Issue 5, 2012, Pages 642-656

  Delisle, Benjamin ^a   Calinescu, Carmen ^b   Mateescu, Mircea Alexandru ^b   Fairbrother, John Morris ^a   Nadeau, Éric ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CARBOXYMETHYLSTARCH SODIUM; CHOLERA TOXIN; CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE A D19; F4 FIMBRIA PROTEIN; FIMBRIA PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG SCREENING; FECES ANALYSIS; GENE EXPRESSION REGULATION; IMMUNIZATION; IMMUNOMODULATION; IN VIVO STUDY; MONOTHERAPY; MUCOSAL IMMUNITY; NONHUMAN; POST WEANING DIARRHEA; SWINE DISEASE; TABLET COMPRESSION; TABLET FORMULATION; UPREGULATION;

EID: 84871146680     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j30w32     Document Type: Article

References (56)

1. Fairbrother JM, Nadeau É, Gyles CL. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Animal health research reviews / Conference of Research Workers in Animal Diseases, 2005; 6:17-39.
2. Van den Broeck W, Cox E, Oudega B, Goddeeris BM. The F4 fimbrial antigen of Escherichia coli and its receptors. Vet Microbiol, 2000; 71:223-244.
3. Freytag LC, Clements JD. Mucosal adjuvants. Vaccine, 2005; 23:1804-1813.
4. Verdonck F, Cox E, van Gog K, Van der Stede Y, Duchateau L, Deprez P, Goddeeris BM. Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain. Vaccine, 2002; 20:2995-3004.
5. Van den Broeck W, Cox E, Goddeeris BM. Induction of immune responses in pigs following oral administration of purified F4 fimbriae. Vaccine, 1999; 17:2020-2029.
6. Van den Broeck W, Cox E, Goddeeris BM. Receptordependent immune responses in pigs after oral immunization with F4 fimbriae. Infect Immun, 1999; 67:520-526.
7. Van den Broeck W, Bouchaut H, Cox E, Goddeeris BM. F4 receptor-independent priming of the systemic immune system of pigs by low oral doses of F4 fimbriae. Vet Immunol Immunopathol, 2002; 85:171-178.
8. Snoeck V, Verfaillie T, Verdonck F, Goddeeris BM, Cox E. The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae. Vaccine, 2006; 24:3812-3820.
9. Calinescu C, Nadeau É, Mulhbacher J, Fairbrother JM, Mateescu MA. Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation. Int J Pharm, 2007; 343:18-25.
10. Calinescu C, Mulhbacher J, Nadeau E, Fairbrother JM, Mateescu MA. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations. Eur J Pharm Biopharm, 2005; 60:53-60.
11. Foss DL, Murtaugh MP. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine. Vaccine, 1999; 17:788-801.
12. Lycke N, Bromander AK, Ekman L, Karlsson U, Holmgren J. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J Immunol, 1989; 142:20-27.
13. Lycke N. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM. Cell Microbiol, 2004; 6:23-32.
14. Murtaugh MP, Foss DL. Inflammatory cytokines and antigen presenting cell activation. Vet Immunol Immunopathol, 2002; 87:109-121.
15. Holmgren J, Adamsson J, Anjuere F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M, Lehner T, Lindblad M, Nygren E, Raghavan S, Sanchez J, Stanford M, Sun JB, Svennerholm AM, Tengvall S. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett, 2005; 97:181-188.
16. Kamstrup S, Verthelyi D, Klinman DM. Response of porcine peripheral blood mononuclear cells to CpGcontaining oligodeoxynucleotides. Vet Microbiol, 2001; 78:353-362.
17. Verfaillie T, Cox E, Goddeeris BM. Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs? Vet Immunol Immunopathol, 2005; 103:141-151.
18. Domeika K, Magnusson M, Eloranta ML, Fuxler L, Alm GV, Fossum C. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Vet Immunol Immunopathol, 2004; 101:87-102.
19. Van der Stede Y, Verdonck F, Verfaillie T, Goddeeris BM, Cox E. Porcine-specific CpGoligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes. Vet Immunol Immunopathol, 2005; 105:115-124.
20. Van der Stede Y, Cox E, Verdonck F, Vancaeneghem S, Goddeeris BM. Reduced faecal excretion of F4+-E. coli by the intramuscular immunisation of suckling piglets by the addition of 1-alpha 2,5-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides. Vaccine, 2003; 21:1023-1032.
21. Zhang L, Tian X, Zhou F. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in weaned piglets. Int Immunopharma, 2006; 6:1623-1631.
22. Levesque S, Martinez G, Fairbrother JM. Improvement of adjuvant systems to obtain a cost-effective production of high levels of specific IgY. Poultry Sci, 2007; 86:630-635.
23. Cadman E, Bostwick JR, Eichberg J. Determination of protein by Lowry procedure in the presence of some commonly used detergents. Anal Biochem, 1979; 96:21-23.
24. Broes A, Fairbrother JM, Lariviere S, Jacques M, Johnson WM. Virulence properties of enterotoxigenic Escherichia coli O8:KX105 strains isolated from diarrheic piglets. Infect Immun, 1988; 56:241-246.
25. Jensen GM, Frydendahl K, Svendsen O, Jorgensen CB, Cirera S, Fredholm M, Nielsen J-P, Moller K. Experimental infection with Escherichia coli O149:F4ac in weaned piglets. Vet Microbiol, 2006; 115:243-249.
26. Wenneras C, Qadri F, Bardhan PK, Sack RB, Svennerholm AM. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect Immun, 1999; 67:6234-6241.
27. Morello CS, Ye M, Hung S, Kelley LA, Spector DH. Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge. J Virol, 2005; 79:159-175.
28. Dozois CM, Oswald E, Gautier N, Serthelon JP, Fairbrother JM, Oswald IP. A reverse transcriptionpolymerase chain reaction method to analyze porcine cytokine gene expression. Vet Immunol Immunopathol, 1997; 58:287-300.
29. Solano-Aguilar GI, Zarlenga D, Beshah E, Vengroski K, Gasbarre L, Junker D, Cochran M, Weston C, Valencia D, Chiang C, Dawson H, Urban JF, Lunney JK. Limited effect of recombinant porcine interleukin-12 on porcine lymphocytes due to a low level of IL-12 beta2 receptor. Vet Immunol Immunopathol, 2002; 89:133-148.
30. Pie S, Lalles JP, Blazy F, Laffitte J, Seve B, Oswald IP. Weaning is associated with an upregulation of expression of inflammatory cytokines in the intestine of piglets. J Nutr, 2004; 134:641-647.
31. Bensaude E, Turner JLE, Wakeley PR, Sweetman DA, Pardieu C, Drew TW, Wileman T, Powell PP. Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of longterm infection of porcine vascular endothelial cells. J Gen Virol, 2004; 85:1029-1037.
32. US Pharmacopeia XXII. US Pharmacopeial Convention, Rockville, MD, pp 1788-1789, 1990.
33. Snoeck V, Huyghebaert N, Cox E, Vermeire A, Vancaeneghem S, Remon JP, Goddeeris BM. Entericcoated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infection. Vet Immunol Immunopathol, 2003; 96:219-227.
34. Verdonck F, Cox E, Van der Stede Y, Goddeeris BM. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response. Vaccine, 2004; 22:4291-4299.
35. Verdonck F, Snoeck V, Goddeeris BM, Cox E. Cholera toxin improves the F4(K88)-specific immune response following oral immunization of pigs with recombinant FaeG. Vet Immunol Immunopathol, 2005; 103:21-29.
36. Olsson E, Smyth CJ, Soderlind O, Svennerholm AM, Mollby R. Development of intestinal antibodies against Escherichia coli antigens in piglets with experimental neonatal E. coli diarrhoea. Vet Microbiol, 1986; 12:119-133.
37. Alexa P, Hamrik J, Stouracova K, Salajka E. Oral immunization against enterotoxigenic collibacillosis in weaned piglets by non-pathogenic Escherichia coli strain with K88 (F4) colonizing factor. Vet Med Czech, 2005; 50:5.
38. Tizard, I., Veterinary Immunology: An introduction, 7th edition. Philadelphia, Saunders, 2004.
39. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev, 2005; 206:32-63.
40. Snoeck V, Peters IR, Cox E. The IgA system: a comparison of structure and function in different species. Vet Res, 2006; 37:455-467.
41. Bianchi AT, Scholten JW, Moonen Leusen BH, Boersma WJ. Development of the natural response of immunoglobulin secreting cells in the pig as a function of organ, age and housing. Dev Comp Immunol, 1999; 23:511-520.
42. Yi AK, Chace JH, Cowdery JS, Krieg AM. IFNgamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol, 1996; 156:558-564.
43. Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol, 1992; 36:983-997.
44. Linghua Z, Xingshan T, Fengzhen Z. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets. Mol Immunol, 2007; 44:1141-1149.
45. Guzylack-Piriou L, Balmelli C, McCullough KC, Summerfield A. Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factoralpha and interleukin-12. Immunology, 2004; 112:28-37.
46. Linghua Z, Xingshan T, Fengzhen Z. In vivo immunostimulatory effects of CpG ODN in newborn piglets. Mol Immunol, 2007; 44:1238-1244.
47. Vollmer J. CpG motifs to modulate innate and adaptive immune responses. Int Rev Immunol, 2006; 25:125-134.
48. Zhang L, Tian X, Zhou F. CpG oligodeoxynucleotides augment the immune responses of piglets to swine Pasteurella multocida living vaccine in vivo. Res Vet Sci, 2007; 83:171-181.
49. Xu W, Tamura T, Takatsu K. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway. Int Immunopharm, 2008; 8:351-361.
50. Verdonck F, Tiels P, Van Gog K, Goddeeris BM, Lycke N, Clements J, Cox E. Mucosal immunisation of piglets with purified F18 fimbriae does not protect against F18+ Escherichia coli infection. Vet Immunol Immunopathol, 2007; 120:69-79.
51. Klinman DM, Currie D, Gursel I, Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev, 2004; 199:201-216.
52. Vajdy M, Srivastava I, Polo J, Donnelly J, O'Hagan D, Singh M. Mucosal adjuvants and delivery systems for protein-, DNA-and RNA-based vaccines. Immunol Cell Biol, 2004; 82:617-627.
53. Verdonck F, De Hauwere V, Bouckaert J, Goddeeris BM, Cox E. Fimbriae of enterotoxigenic Escherichia coli function as a mucosal carrier for a coupled heterologous antigen. J Control Release, 2005; 104:243-258.
54. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine, 2007; 25:5467-5484.
55. Lycke NY. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. J Immunol, 1993; 150:4810-4821.
56. Akhiani AA, Schon K, Lycke N. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice. J Immunol, 2004; 173:3348-3356.